Russia has recently declared it has found a cure for cancer in the form of vaccine that targets cancer patients. Planned to be ready for the mass production in early 2025, the vaccine will be fully paid from the state’s budget and free for the Russian people based on official media outlets.

This bespoke approach involves extracting genetic information from the cancerous tissue of the patient and subsequent mobilisation of the patient’s own immune system to recognise such tumourigenic markers. Thus, according to Andrey Kaprin, the head of the Radiology Medical Research Centre, the vaccine is intended to cure existing cancers rather than to prevent the formation of carcinoma tumours.

The vaccine, which costs around 300 thousand rubles ($2,869) per dose, employs a complex production technique. Alexander Gintsburg, the director of the Gamaleya National Research Centre said that artificial intelligence cuts the time required to fine tune the human mRNA vaccine using neural network computing to half an hour to one hour at most.

This innovation has arrived particularly as Russia continues to register an upward trend of cancer incidences with over 635, 000 new cases in the year 2022 of which were colon, breast, lung cancers among others.

Similar to developments all over the world, Russia also moved in creating personalized cancer care treatments. The united states recently conducted a trial of what can be called a

personalised vaccine for glioblastoma ,and the body responded within days. Likewise, the UK is already testing a melanoma vaccine, showing better survival prospect.

This revolutionary vaccine is already holding the promise of new life to people diagnosed with cancer and a signal advancement in the concept of custom-built treatment.